/Tag: US FDA

India needs a meaningful bond market

2018-08-06T13:40:26+00:00February 9th, 2017|2017/2018, Emerging Markets, February 2017, Year|

Parag Saxena is the CEO of New Silk Route Partners, one of India’s largest Private Equity (PE) funds with a primary focus on India and the Southeast Asia markets. He tells ‘India Global Business’ about the company’s journey since inception in 2006 to becoming a leading Asia-focused growth capital firm with $1.4 billion under management. How is New Silk Route contributing to the Indian growth story? New Silk Route was formed with the belief that as India’s GDP per capita [...]